(Q33897211)

29 July 2017

1 reference

title

Drugs used to treat spasticity (English)

1 reference

29 July 2017

1 reference

Kita M

1

1 reference

29 July 2017

Goodkin DE

series ordinal

2

1 reference

29 July 2017

publication date

1 March 2000

1 reference

29 July 2017

1 reference

29 July 2017

volume

59

1 reference

29 July 2017

issue

3

1 reference

29 July 2017

page(s)

487-495

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200059030-00006

29 July 2017

exact match

0 references

cites work

THE USE OF DIAZEPAM IN HEMIPLEGIA

1 reference

12 December 2020

Efficacy and safety of tizanidine in the treatment of spasticity in patients with spinal cord injury. North American Tizanidine Study Group

1 reference

12 December 2020

Molecular Mechanisms in the Receptor Action of Benzodiazepines

1 reference

12 December 2020

Effect of treatment with botulinum toxin on spasticity

1 reference

12 December 2020

A randomised, double blind, placebo controlled trial of botulinum toxin in the treatment of spastic foot in hemiparetic patients

1 reference

12 December 2020

Update on multiple sclerosis therapy.

1 reference

12 December 2020

Use of clonidine for treatment of spasticity arising from various forms of brain injury: a case series

1 reference

12 December 2020

Medical treatment for spasticity in children with cerebral palsy

1 reference

12 December 2020

Clonidine effect on spasticity: a clinical trial.

1 reference

12 December 2020

Botulinum toxin in severe upper extremity spasticity among patients with traumatic brain injury: an open-labeled trial.

1 reference

12 December 2020

Effect of intrathecal baclofen on bladder and sphincter function

1 reference

12 December 2020

Mechanisms of tizanidine action on spasticity

1 reference

12 December 2020

Baclofen in the Treatment of Spasticity

1 reference

12 December 2020

The effect of dantrolene sodium on spasticity in multiple sclerosis

1 reference

12 December 2020

Clinical pharmaco--physiology of dantrolene sodium

1 reference

12 December 2020

Management of spasticity in cerebral palsy with botulinum-A toxin: report of a preliminary, randomized, double-blind trial

1 reference

12 December 2020

A double-blind comparative trial of new muscle relaxant, tizanidine (DS 103-282), and baclofen in the treatment of chronic spasticity in multiple sclerosis

1 reference

12 December 2020

Baclofen versus diazepam for the treatment of spasticity and long-term follow-up of baclofen therapy.

1 reference

12 December 2020

Intrathecal baclofen for long-term treatment of spasticity: a multi-centre study

1 reference

12 December 2020

Intrathecal baclofen for spasticity

1 reference

12 December 2020

Continuous intrathecal baclofen infusion for spasticity of cerebral origin

1 reference

12 December 2020

A comparison of dantrolene sodium and diazepam in the treatment of spasticity.

1 reference

12 December 2020

Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial.

1 reference

12 December 2020

Mechanisms of baclofen action on spasticity

1 reference

12 December 2020

Botulinum toxin in the management of the lower limb in cerebral palsy

1 reference

12 December 2020

Double-blind study on the antispastic effect of beta-94-chlorphenyl)-gamma aminobutyric acid (CIBA) in multiple sclerosis

1 reference

12 December 2020

Mechanism of control of skeletal-muscle contraction by dantrolene sodium

1 reference

12 December 2020

Spasticity in spinal cord injured persons: quantitative effects of baclofen and placebo treatments.

1 reference

12 December 2020

The mode of action of the gaba derivative baclofen in human spasticy

1 reference

12 December 2020

Dantrolene sodium: a review of its pharmacological properties and therapeutic efficacy in spasticity

1 reference

12 December 2020

The treatment of spasticity in multiple sclerosis: a double-blind clinical trial of a new anti-spastic drug tizanidine compared with baclofen

1 reference

12 December 2020

The action of diazepam in neurological disorders with excessive motor activity

1 reference

12 December 2020

A double-blind trial with baclofen (Lioresal) and diazepam in spasticity due to multiple sclerosis

1 reference

12 December 2020

Antispasticity drugs: mechanisms of action

1 reference

12 December 2020

PRELIMINARY TRIAL OF CARISOPRODOL IN MULTIPLE SCLEROSIS

1 reference

12 December 2020

Treatment of spasticity with tizanidine in multiple sclerosis

1 reference

12 December 2020

Effectiveness of gabapentin in controlling spasticity: a quantitative study.

1 reference

12 December 2020

The Use of Baclofen in Treatment of Spasticity in Multiple Sclerosis

1 reference

12 December 2020

Tizanidine versus baclofen in the treatment of spasticity in patients with multiple sclerosis.

1 reference

12 December 2020

Tizanidine versus baclofen in the treatment of spasticity in multiple sclerosis patients

1 reference

12 December 2020

An evaluation of baclofen treatment for certain symptoms in patients with spinal cord lesions. A double-blind, cross-over study

1 reference

12 December 2020

Tizanidine in the treatment of spasticity

1 reference

12 December 2020

Intrathecal baclofen for spasticity of spinal origin: seven years of experience

1 reference

12 December 2020

Selective depression of synaptic transmission of spinal neurones in the cat by a new centrally acting muscle relaxant, 5-chloro-4-(2-imidazolin-2-yl-amino)-2, 1, 3-benzothiodazole (DS103-282)

1 reference

12 December 2020

Comparison of dantrolene sodium and diazepam in the treatment of spasticity

1 reference

12 December 2020

Treatment of Spasticity in Multiple Sclerosis With Dantrolene

1 reference

12 December 2020

Intrathecal application of drugs for muscle hypertonia

1 reference

12 December 2020

Intrathecal baclofen for severe spinal spasticity

1 reference

12 December 2020

Clinical assessment and pharmacologic therapy of spasticity.

1 reference

12 December 2020

Intrathecal baclofen therapy for adults with spinal spasticity: therapeutic efficacy and effect on hospital admissions

1 reference

12 December 2020

Liorseal, a new muscle relaxant in the treatment of spasticity--a double-blind quantitative evaluation

1 reference

12 December 2020

A multi-centre, double-blind trial of tizanidine, a new antispastic agent, in spasticity associated with hemiplegia.

1 reference

12 December 2020

Multi-centre, double-blind trial of a novel antispastic agent, tizanidine, in spasticity associated with multiple sclerosis

1 reference

12 December 2020

Lioresal (baclofen) treatment of spasticity in multiple sclerosis

1 reference

12 December 2020

A new agent for the control of spasticity

1 reference

12 December 2020

Mode of action of dantrolene sodium in spasticity

1 reference

12 December 2020

Treatment of spasticity with botulinum toxin: a double-blind study

1 reference

12 December 2020

Gabapentin for relief of spasticity associated with multiple sclerosis

1 reference

12 December 2020

Reflex changes induced by clonidine in spinal cord injured patients.

1 reference

12 December 2020

The long-term safety and efficacy of gabapentin (Neurontin) as add-on therapy in drug-resistant partial epilepsy. The US Gabapentin Study Group

1 reference

12 December 2020

High-dose oral baclofen: experience in patients with multiple sclerosis

1 reference

12 December 2020

A double-blind, placebo-controlled trial of tizanidine in the treatment of spasticity caused by multiple sclerosis. United Kingdom Tizanidine Trial Group

1 reference

12 December 2020

Diazepam in the Relief of Muscle Spasm Resulting from Spinal-Cord Lesions

1 reference

12 December 2020

Is the muscle relaxant effect of diazepam in spastic mutant rats mediated through GABA-independent benzodiazepine receptors?

1 reference

12 December 2020

Objective assessment of spasticity, strength, and function with early exhibition of dantrolene sodium after cerebrovascular accident: a randomized double-blind study

1 reference

12 December 2020

A double blind, cross-over trial of valium in the treatment of spasticity

1 reference

12 December 2020

Gabapentin: discussion

1 reference

12 December 2020

A comparison of baclofen and diazepam in the treatment of spasticity

1 reference

12 December 2020

10.2165/00003495-200059030-00006

Identifiers

DOI

1 reference

Dimensions Publication ID

29 July 2017

1044323864

0 references

1 reference